Hengchu Cao, PhD,
Sr. Director, Engineering and Advanced Technology,
Dr. Hengchu Cao has over thirty years of research and development experience in medical device industry. At present, Dr. Cao is a Senior Director of Engineering in Advanced Technology at Edwards Lifesciences. Over the past decade, he has made substantial contribution to the development, regulatory approval, and commercialization of the break-through transcatheter heart valve technology. In particular, Dr. Cao developed an innovative approach to apply computer modeling and simulation technology to the design and life time prediction of the transcatheter heart valve structures.
Dr. Cao has made a personal commitment to excellence on medical device technology. He is the inventor of many implantable heart devices with nine patents. His industrial experience spans from startup to world's largest and fastest growing heart valve company. His invention of a ceramic-based blood pump at a start-up company contributed significantly to the successful commercialization of the world's first total suspended wearless ventricular assist device.
Dr. Cao is an active member of several professional organizations. He is a fellow of the American Institute for Medical and Biological Engineering. He served on the organizing committee for FDA/BMES Frontiers in Medical Device Modeling and Simulation. He was on the organizing committee for 1st FDA/ASME Frontiers in Medical Devices in 2013 as well on the National Academy BEMA roundtable for Medical Device In Vitro Evaluation in 2006. Dr. Cao holds a BS in chemical engineering from South China University of Technology, and a PhD in materials science from University of California at Berkeley.